...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Upcoming Presentations
9
Oct 16, 2020 12:40PM
2
Oct 16, 2020 12:55PM
4
Oct 16, 2020 01:01PM
2
Oct 16, 2020 01:43PM
5
Oct 16, 2020 03:47PM
6
Oct 16, 2020 05:02PM
4
Oct 16, 2020 06:56PM
2
Oct 16, 2020 08:25PM
7
Oct 16, 2020 09:48PM
5
Oct 16, 2020 10:24PM
1
Oct 16, 2020 11:02PM
12
Oct 17, 2020 12:20AM
3
Oct 17, 2020 05:33AM
9
Oct 17, 2020 12:13PM
14
Oct 17, 2020 05:32PM
10
Oct 17, 2020 06:15PM
3
Oct 18, 2020 07:56AM
9
Oct 18, 2020 10:34AM
15
Oct 18, 2020 05:53PM
16
Oct 19, 2020 08:18AM
10
Oct 19, 2020 08:57AM
1
Oct 19, 2020 09:14AM
8
Oct 19, 2020 10:29AM
3
Oct 19, 2020 11:02AM
7
ARR
Oct 19, 2020 11:18AM
10
Oct 19, 2020 11:30AM
1
Oct 19, 2020 12:03PM
1
Oct 19, 2020 12:04PM
9
Oct 19, 2020 12:57PM
2
Oct 19, 2020 01:34PM
1
Oct 19, 2020 02:33PM

"Finally this data will be presented: "Results of new data analysis in the chronic kidney disease (CKD) pre-specified subpopulation of BETonMACE will be presented"

The abstract for the upcoming BETonMACE CKD subgroup presentation at ASN Kidney Week seems to be nearly identical to the conent presented in June 2020 at ERA-EDTA. I am not expecting anything new. The other ASN Kidney Week abstract appears to be focusing on pre-clinical and Phase 2 alkaline phosphatase data. Again, old news. Sound like these will be available starting Oct 22nd, so we will know for sure soon enough. 

BDAZ

4
Oct 19, 2020 03:20PM
8
Oct 19, 2020 03:41PM
2
Oct 19, 2020 04:18PM
7
Oct 19, 2020 04:51PM
1
Oct 19, 2020 05:43PM
11
Oct 19, 2020 06:15PM
2
Oct 19, 2020 07:10PM
1
Oct 20, 2020 04:24AM
1
Oct 20, 2020 04:31AM
3
Oct 20, 2020 04:52AM
5
Oct 20, 2020 08:38AM
11
Oct 20, 2020 09:34AM
6
Oct 20, 2020 09:43AM
10
Oct 20, 2020 09:52AM
3
Oct 20, 2020 09:58AM
10
Oct 20, 2020 10:28AM
18
Oct 20, 2020 10:48AM
1
Oct 20, 2020 10:54AM
7
Oct 20, 2020 01:19PM
9
Oct 20, 2020 03:04PM
2
Oct 20, 2020 06:47PM
9
Oct 20, 2020 08:08PM
4
Oct 21, 2020 03:45AM
3
Oct 21, 2020 11:22AM
4
Oct 21, 2020 01:28PM
Share
New Message
Please login to post a reply